About James La Rossa

This author has not yet filled in any details.
So far James La Rossa has created 179 blog entries.

Smoking Cessation Drug May Boost Cognition in Schizophrenia

By |2021-11-11T17:14:20-08:00March 22nd, 2017|Brief Bulletins from the Field, We Know Psychiatry|

In findings reported in a letter to the editor published online March 10 in Schizophrenia Research and reported by Medscape Medical News, the smoking cessation drug varenicline (Chantix) appears to enhance cognition in nonsmoking individuals with and those without schizophrenia. The results also showed that the drug reduced the cognitive [...]

Powerful New Chinese Opioid Intensifies Crisis: Carfentanil linked to at least 700 deaths

By |2021-11-11T17:14:28-08:00February 18th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Carfentanil, an opioid said to be 100 times more powerful than fentanyl, has been tied to at least 700 deaths in numerous states. Worst hit include Michigan, Florida, and Ohio, according to data compiled by US authorities. Carfentanil was originally intended to sedate large animals, such as elephants, and is [...]

OPINION: Recent Study Critical of Psychotropic Prescribing in the Elderly May Belie Real World Treatment

By |2021-11-11T17:14:40-08:00February 14th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

The number of retirement-age Americans taking at least three psychiatric drugs more than doubled between 2004 and 2013, even though almost half of them had no mental health diagnosis on record, according to a new study published in JAMA Internal Medicine and reported in today's New York Times. The new [...]

Psychopharmacology Bulletin, Volume 47, Number 1, 2017 On-Line Now

By |2021-11-11T17:14:49-08:00January 31st, 2017|Brief Bulletins from the Field, We Know Psychiatry|

The latest edition of Psychopharmacology Bulletin is now available at: https://medworksmedia.com/product-category/psychopharmacology-bulletin/psychopharmacology-47-no-1/. Manuscripts include: Asenapine for the Control of Physical Aggression: A Prospective Naturalist Pilot Study By Jin Shi Amon, Sarah B. Johnson, Rif S. El-Mallakh A Review of Psychopharmacological Interventions Post-Disaster to Prevent Psychiatric Sequelae By Badari Birur, Suresh Bada Math, Rachel E. Fargason [...]

Tailored Exercise Can Be a Boon to People With Parkinson’s Disease

By |2021-11-11T17:14:58-08:00January 24th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

In a surprise to the conservative treatments by neurologists, tailored exercise treatment programs are being developed by physical therapists to specifically counter the unique movement impairments associated with Parkinson’s by training patients to make big strong movements that incorporate the principles of tai chi and boxing. Treatments can, as well, [...]

Ecstasy (MDMA) and Hallucinogenic (Psilocybin) Show Significant Psychiatric Benefits for PTSD and Cancer Patients

By |2021-11-11T17:16:19-08:00December 2nd, 2016|Brief Bulletins from the Field, We Know Psychiatry|

Promising research into PTSD and the psychological effects of cancer such as anxiety and depression, have cast new light on the party drug, ecstasy (MDMA), and a hallucinogenic ingredient in "Magic Mushrooms" (psilocybin). In a paper posted online, Michael and Ann Mithoefer, the husband-and-wife team offering the treatment — which combines [...]

Surgeon General’s Report: Toll on Addictions top $400 Billion, Few are Treated

By |2021-11-11T17:16:28-08:00November 18th, 2016|Brief Bulletins from the Field, We Know Psychiatry|

While the debate rages whether the drug epidemic in the United States is best served by walls or treatment, millions of Americans suffer from alcoholism or addiction to legal and illegal drugs, but only a fraction are being treated, according to a report released on Thursday by the surgeon general. [...]

Do Like Yogis: Controlled Breathing is a ‘Scientific’ Source of Relief

By |2021-11-11T17:16:36-08:00November 15th, 2016|Brief Bulletins from the Field, We Know Psychiatry|

For centuries yogis have used breath control, or pranayama, to promote concentration and improve vitality. Buddha advocated breath-meditation as a way to reach enlightenment. Science is just beginning to provide evidence that the benefits of this ancient practice are real. Studies have found, for example, that breathing practices can help [...]

Psychopharmacology Bulletin: 36 Articles Uploaded to PubMed

By |2016-10-14T17:07:53-07:00October 14th, 2016|We Know Psychiatry|

psychopharmacology-bulletin-36-articles-uploaded-to-pubmed   October 13, 2016. Los Angeles CA Contact: James La Rossa Jr., or Michael E. Thase, MD, at 310.374.1300 www.medworksmedia.com Psychopharmacology Bulletin 36 Articles Uploaded to PubMed Replica Journal Issue Available for Readers Zonisamide for Bipolar Disorder, Mania or Mixed States: A Randomized, Double Blind, Placebo-Controlled Adjunctive Trial Deborah [...]

New Issue of Psychopharmacology Bulletin: Paliperidone, Asenapine, Dextromethorphan, and More

By |2016-08-19T15:37:36-07:00August 19th, 2016|We Know Psychiatry|

https://medworksmedia.com/product-category/psychopharmacology-bulletin/psychopharmacology-46-2/ For Immediate Release August 18, 2016. Los Angeles CA Contact: James La Rossa Jr., or Michael E. Thase, MD, at 310.374.1300 New Issue of Psychopharmacology Bulletin ORIGINAL RESEARCH An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder Patricia Pilkinton, Carlos Berry, Seth Norrholm, [...]

Go to Top